iBET/ITQB and SCIEX SEMINAR: Advancing Biologics Characterization by Mass Spectrometry
The recent developments in analytical technologies for biopharmaceutical characterization.
iNOVA4HEALTH SEMINAR: “Development of Live Bacterial Therapeutics“
By John G. Aunins, PhD – Executive Vice President and Chief Technology Officer at Seres Therapeutics, Inc.
iBET-ITQB CONFERENCE: “Global Healthcare Context and Corresponding Biopharma Manufacturing Trends”
By Dr Günter Jagschies – Senior Manager in Business and R&D, GE Healthcare Life Sciences
INOVA4HEALTH SEMINAR: “Hormones and breast cancer: how models matter”
By Dr Cathrin Brisken – Associate Professor of Life Sciences, Swiss Federal Institute of Technology & Co-Director...
iBET-ITQB CONFERENCE: “The Pharmaceutical Cluster – Key Trends and the Portuguese Opportunities”
Daniel F. Guedelha, MSc, MBA Global Strategy Operations NOVARTIS | Basel
iNOVA4Health Seminar: “Targeting macrophages at the tumour microenvironment”
By Maria José Oliveira – Group Leader, Tumour and Microenvironment Interaction Group, i3S, Porto
iNOVA4Health Seminar: “Therapeutics for myocardial repair – moving forward ?”
By Joost Sluijter, PhD – Professor of Cellular and Translational Cardiology, University Medical Center-Utrecht
iNOVA4Health Seminar: “Cellular Thermal Shift Assay (CETSA) – Case study @ Protein Technologies (Bayer AG)”
Dr. Jörg Weiske – Head of Protein Technologies, R&D, Pharmaceuticals at Bayer AG
iBET-ITQB Seminar: Structure-guided Fragment-based Drug Discovery for Cancer and Tuberculosis: Fighting the Emergence of Resistance
By Professor Tom L. Blundell, Cambridge University, UK